Envista (NVST)

• Market cap: $3.49B
• 1 day: -0.57%
• 5 days: 0.77%
• 1 month: 1.01%
• 3 months: 13.84%
• 6 months: 22.19%
• Year to date: 9.79%
• 1 year: 10.42%
• 5 years: -18.17%
• 10 years: -24.94%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Employees: 12,300

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

1,260% more call options, than puts

Call options by funds: $7.15M | Put options by funds: $526K

100% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 4 (+2) [Q2]

16% more capital invested

Capital invested by funds: $3.33B [Q1] → $3.86B (+$529M) [Q2]

4.5% more ownership

Funds ownership: 111.99% [Q1] → 116.49% (+4.5%) [Q2]

9% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 47

2% less funds holding

Funds holding: 286 [Q1] → 279 (-7) [Q2]

21% less repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 117

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $17
• Avg. target: $20
• High target: $25

7 analyst ratings

• positive: 2 29%
• neutral: 4 57%
• negative: 1 14%

Mizuho Steven Valiquette	$18	Underperform Maintained	1 Aug 2025
Stifel Jonathan Bock	$25	Buy Maintained	1 Aug 2025
Morgan Stanley Erin Wright	$17	Equal-Weight Maintained	1 Aug 2025
Wells Fargo Vik Chopra	$19	Equal-Weight Maintained	1 Aug 2025
Piper Sandler Jason Bednar	$19	Neutral Maintained	1 Aug 2025